BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9541684)

  • 21. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
    Akyurek N; Uner A; Benekli M; Barista I
    Cancer; 2012 Sep; 118(17):4173-83. PubMed ID: 22213394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma.
    Romaguera JE; Pugh W; Luthra R; Goodacre A; Cabanillas F
    Ann Oncol; 1993 Jan; 4(1):51-4. PubMed ID: 8435363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.
    Gascoyne RD; Adomat SA; Krajewski S; Krajewska M; Horsman DE; Tolcher AW; O'Reilly SE; Hoskins P; Coldman AJ; Reed JC; Connors JM
    Blood; 1997 Jul; 90(1):244-51. PubMed ID: 9207459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma.
    Raghoebier S; Kramer MH; van Krieken JH; de Jong D; Limpens J; Kluin-Nelemans JC; van Ommen GJ; Kluin PM
    Blood; 1991 Nov; 78(10):2680-5. PubMed ID: 1824261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 expression in large B-cell lymphomas with MYC extra copies and CD99 expression in large B-cell lymphomas in relation to MYC status.
    Richardson AI; Zhang D; Woodroof J; Cui W
    Hum Pathol; 2019 Apr; 86():21-31. PubMed ID: 30496802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical characteristics and prognosis of concurrent positive t(14; 18) and myc gene rearrangement in diffuse large B cell lymphoma].
    Zhang HW; Chen ZW; Wang LY; He JX; Zheng YP; Han WE; Yang B; Wang YL; Zhao ZQ; Bai M; Su LP
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):206-10. PubMed ID: 26988827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
    Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
    Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin.
    Liang R; Chan WP; Kwong YL; Xu WS; Srivastava G; Ho FC
    Cancer Genet Cytogenet; 1997 Sep; 97(2):114-8. PubMed ID: 9283593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inferior survival in high-grade B-cell lymphoma with
    McPhail ED; Maurer MJ; Macon WR; Feldman AL; Kurtin PJ; Ketterling RP; Vaidya R; Cerhan JR; Ansell SM; Porrata LF; Nowakowski GS; Witzig TE; Habermann TM
    Haematologica; 2018 Nov; 103(11):1899-1907. PubMed ID: 29903764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.
    Offit K; Lo Coco F; Louie DC; Parsa NZ; Leung D; Portlock C; Ye BH; Lista F; Filippa DA; Rosenbaum A
    N Engl J Med; 1994 Jul; 331(2):74-80. PubMed ID: 8208268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical characteristics of high-grade B-cell lymphomas with rearrangement of MYC, bcl-6 and bcl-2].
    Gong JY; Zhang YZ; Zhang JD; Zhang W; Li JQ; Ru K; Liu EB
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):14-18. PubMed ID: 29325245
    [No Abstract]   [Full Text] [Related]  

  • 35. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
    Ueda C; Nishikori M; Kitawaki T; Uchiyama T; Ohno H
    Int J Hematol; 2004 Jan; 79(1):52-4. PubMed ID: 14979479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
    Landsburg DJ; Falkiewicz MK; Petrich AM; Chu BA; Behdad A; Li S; Medeiros LJ; Cassaday RD; Reddy NM; Bast MA; Vose JM; Kruczek KR; Smith SE; Patel P; Hernandez-Ilizaliturri F; Karmali R; Rajguru S; Yang DT; Maly JJ; Blum KA; Zhao W; Vanslambrouck C; Nabhan C
    Br J Haematol; 2016 Nov; 175(4):631-640. PubMed ID: 27469075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
    Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.
    Kondo E; Yoshino T; Akagi T; Hayashi K; Takahashi K
    Acta Med Okayama; 1992 Dec; 46(6):407-15. PubMed ID: 1485535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
    Lin P; Dickason TJ; Fayad LE; Lennon PA; Hu P; Garcia M; Routbort MJ; Miranda R; Wang X; Qiao W; Medeiros LJ
    Cancer; 2012 Mar; 118(6):1566-73. PubMed ID: 21882178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
    Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.